Associate feedback and a high trust culture are key contributors to earning the prestigious ranking
Dorval, Quebec, April 15, 2020 – Novartis Pharmaceuticals Canada Inc. is proud to announce that the company has been named to the 2020 list of Best Workplaces™ in Canada. The ranking has been made possible thanks to feedback from Canada-based employees across the Novartis businesses. Associates from the Novartis Innovative Medicines Division (Pharmaceuticals and Oncology business units), as well as Sandoz Canada weighed in, contributing to the prestigious ranking.
The highly respected recognition program run by the Great Place to Work® Institute gathers and evaluates employee feedback and acknowledges companies who have built high-trust, high-performance workplace cultures. The list evaluates like-sized companies from across Canada that are measured against criteria designed to identify those that are exceptional places to work.
“Novartis is extremely honoured to receive this recognition. The fact that our associates have responded positively to the survey is validation that we are succeeding in cultivating a positive and inspiring work environment, a catalyst to achieving our purpose to reimagine medicine for the Canadian patients who count on us,” said Christian Macher, Country President, Novartis Pharmaceuticals Canada Inc. “Our associates are our ambassadors and the force that delivers excellence in everything we do. We strive to unleash the power of our people to make them feel valued and empowered and want to be known for being the employer of choice within our industry.”
In Canada, the team of approximately 1,000 Novartis associates from the Innovative Medicines division comprising the Pharmaceuticals and Oncology business units, and generic pharmaceuticals and biosimilars division, Sandoz, are dedicated to helping Canadians live better and healthier lives. The goal is to create an organization with top talent who have the expertise and drive to succeed.
The company prides itself on its commitment to diversity and to nurturing an inclusive environment all around. Novartis is also committed to be an ethical and responsible corporate citizen in Canada through its employment practices, as well as through its research programs and commercial activities and by always showing respect for the environment.
Great Place to Work® is the global authority on high-trust, high-performance workplace cultures. Through proprietary assessment tools, advisory services, and certification programs, it recognizes the Best Workplaces™ across the world in a series of national lists published in leading newspapers and magazines.
About Novartis in Canada Novartis Pharmaceuticals Canada Inc., a leader in the healthcare field, is committed to the discovery, development and marketing of innovative products to improve the well-being of all Canadians. In 2018, the company invested $52 million in research and development in Canada. Located in Dorval, Quebec, Novartis Pharmaceuticals Canada Inc. employs approximately 1,000 people in Canada and is an affiliate of Novartis AG, which provides innovative healthcare solutions that address the evolving needs of patients and societies. For further information, please consult www.novartis.ca.
About Sandoz in Canada Sandoz Canada is part of Sandoz International GmbH, a global leader in generic pharmaceuticals and biosimilars and a pioneer in the emerging field of prescription digital therapeutics, and a division of Swiss multinational Novartis AG. A leader in its field, Sandoz Canada markets and distributes a broad line of generic, biosimilar and specialty products. For more information, visit www.sandoz.ca. Follow us on LinkedIn: https://www.linkedin.com/company/sandoz-canada/
About Novartis globally Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach more than 750 million people globally and we are finding innovative ways to expand access to our latest treatments. About 109,000 people of more than 145 nationalities work at Novartis around the world. Find out more at www.novartis.com.